Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Lacrimal gland gene expression elevated by treatment of mice with LTBR-Ig compared to control

From: Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome

  Gene Fold Change Up
Spt2 salivary protein 2 116.39
Ren1 renin 1 structural 108.03
Crisp3 cysteine-rich secretory protein 3 88.55
Klk1b26 kallikrein 1-related petidase b26 83.06
Klk1b16 kallikrein 1-related peptidase b16 71.72
Abpb androgen binding protein beta 51.14
Klk1b5 kallikrein 1-related peptidase b5 43.58
Klk1b9 kallikrein 1-related peptidase b9 42.18
Klk1b4 kallikrein 1-related pepidase b4 31.05
Klk1b8 kallikrein 1-related peptidase b8 30.37
Klk1b3 kallikrein 1-related peptidase b3 30.26
Muc10 mucin 10, submandibular gland salivary mucin 26.56
Egfbp2 epidermal growth factor binding protein type B 23.63
Klk1b4 kallikrein 1-related pepidase b4 18.95
Klk1b1 kallikrein 1-related peptidase b1 18.63
Smr2 submaxillary gland androgen regulated protein 2 15.83
Klk1b27 kallikrein 1-related peptidase b27 15.45
Klk1b21 kallikrein 1-related peptidase b21 14.58
Abpa androgen binding protein alpha 9.94
Ngfb nerve growth factor, beta 9.06
Klk1b24 kallikrein 1-related peptidase b24 8.59
Egf epidermal growth factor 5.92
Klk1b11 kallikrein 1-related peptidase b11 5.29